Sotera Health Company (SHC)
NASDAQ: SHCHealth CareMisc Health and Biotechnology ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
SHC stock chart
Technical analysisKey statistics
All statistics- Market cap
- $4.54B
- P/E (TTM)
- 26.52
- Forward P/E
- 14.94
- EPS (TTM)
- $0.60
- Dividend yield
- None
- 52-week range
- 13.09 – 19.85
- Day range
- 15.81 – 16.31
- Volume / Avg
- 1.73M / 2.20M
- Beta
- —
- Shares outstanding
- 285.63M
52-week range
SHC stock today
Sotera Health (SHC) closed at $15.91 on Nov 20, down 1.85% (-$0.30), versus the S&P 500's 3.70% decline. At this level, SHC sits in the middle of its 52-week range of $13.09 to $19.85: 19.8% below the high, set on Jan 9, 2026 and 21.5% above the low. SHC is down 9.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 2.6%.
At 26.5x trailing earnings, Sotera Health trades above the peer-group median of 22.4x. Its forward P/E of 14.9x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Sotera Health
Company profileSotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets.
- Sector
- Health Care
- Industry
- Misc Health and Biotechnology Services
- CEO
- Mr. Alton E. Shader
- Headquarters
- Broadview Heights, OH
- Employees
- 3,000
- IPO year
- 2020
- Website
- soterahealth.com
Financial highlights
Full financialsIn fiscal 2025, Sotera Health generated $1.16 billion in revenue, up 5.7% from fiscal 2024, its 6th consecutive year of revenue growth. Net income was $77.9 million (+75.6% year over year), for a net margin of 6.7% versus a median of 4.0% in the prior 5 years. Gross margin was 55.5% (up from 54.7%).
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $1.16B | $1.10B | $1.05B | $1.00B | $931.48M |
| Growth | +5.74% | +4.88% | +4.54% | +7.75% | +13.85% |
| Net income | $77.95M | $44.40M | $51.38M | $-233.57M | $116.88M |
| EPS (diluted) | $0.27 | $0.16 | $0.18 | $-0.83 | $0.41 |
Analyst forecast
ForecastConsensus (10 analysts)
buy
Avg. price target
$21.44+34.76%
- Strong buy 3
- Buy 5
- Hold 1
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 3, 2026
- EPS actual vs est.
- $0.20 vs $0.24
- Surprise
- -16.67%
SHC news
All SHC news- Do Options Traders Know Something About Sotera Health Stock We Don't?Nasdaq
- Why is Sotera Health stock sliding today?Investing.com
- Sotera Health reaffirms 2026 outlook, targets adjusted EPS of $0.95 to $1.01 amid European med device softnessSeeking Alpha
- Sotera Health beats top-line and bottom-line estimates; reaffirms FY26 outlookSeeking Alpha
- Sotera Health Company (SHC) Beats Q3 Earnings and Revenue EstimatesNasdaqSHC, VTRS
- Sotera Health Reports Solid Third-Quarter and Year-to-Date 2026 ResultsGlobeNewswire
- Stocks Retreat on Sticky US Price PressuresNasdaqBLK, AMAT, SNDK, DHI
Sotera Health peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PGNYProgyny Inc. | 35.71 | +0.73% | $2.63B | vs SHC |
| AGLagilon health inc. | 90.24 | +0.83% | $1.52B | vs SHC |
| VMDViemed Healthcare Inc. | 8.52 | -1.05% | $322.85M | vs SHC |
| PARKPark Dental Partners Inc. | 17.03 | -6.79% | $94.26M | vs SHC |
| CCELCryo-Cell International Inc. | 4.15 | 0.00% | $33.46M | vs SHC |
| MGRXMangoceuticals Inc. | 0.1236 | -7.55% | $2.75M | vs SHC |
| NIVFNewGenIvf Group Limited Class A | 0.0269 | -23.14% | $80.77K | vs SHC |
| DVADaVita Inc. | 161.03 | +3.00% | $10.13B | vs SHC |
Indexes, lists and sector
Sotera Health stock FAQ
What is Sotera Health's stock price today?
SHC last traded at $15.91 as of Nov 20, 4:00 PM EST, down 1.85% on the day. Prices are delayed at least 15 minutes.
What is SHC's P/E ratio?
SHC trades at a trailing P/E ratio of 26.52 and a forward P/E of 14.94, compared with a median of 22.4 for its closest peers.
Who is Sotera Health's CEO?
Mr. Alton E. Shader is the chief executive officer of Sotera Health Company, which has about 3,000 employees.
What is the SHC 52-week high?
The 52-week high for SHC is $19.85 and the 52-week low is $13.09. The stock is currently 19.8% below its high.